| Course | MKT 445 Marketing Research and Reporting |
|---|---|
| Topic | Topic 8 |
| Paper type | Study limitations defense |
| Length | About 970 words, 2 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | BS in Marketing |
| Updated | October 2026 |
Free sample paper for MKT 445 Topic 8
What 1,150 Followers Can and Cannot Support: Redrawing a Skincare Brand's Four Advertising Claims Until the Evidence Carries Them
[Author Name]
Colangelo College of Business, Grand Canyon University
MKT-445: Marketing Research and Reporting
Topic 8 Limitations Defense
[Instructor Name]
[Date]
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
What 1,150 Followers Can and Cannot Support: Redrawing a Skincare Brand's Four Advertising Claims Until the Evidence Carries Them
The Study and the Request
A composite skincare brand posted a survey link on its social media accounts asking followers about its new serum. About 1,150 followers responded. The brand's director has drafted four advertising claims from the results and wants to present them as national findings about women's preferences. This defense sets each claim against what the study can support, gives a verdict, and rewrites each claim in language the evidence carries. It is not an argument against using the study; it is an argument for using it accurately. All figures are illustrative.
Claim One: Most Women Prefer the Serum to Leading Brands
Verdict: fails on the sample. The 1,150 respondents are followers of the brand who chose to answer. They are not a sample of women in general, and they were not selected at random from any defined population. Followers already favor the brand, which is why they follow it, so their preferences overstate how the serum compares with leading brands among women who do not follow it. Groves (2006) showed that nonresponse bias depends on whether the survey topic is related to the decision to respond; here, enthusiasm for the brand plausibly drove both following and answering.
Supported version: Among 1,150 of our followers who answered a survey, most said they preferred the new serum to other brands they had used.
Claim Two: The Serum Reduces Breakouts
Verdict: fails on design. The survey found that users reported fewer breakouts since starting the serum. A survey of this kind cannot separate the product's effect from everything else those users did at the same time, such as changing other products, the season, or simply noticing their skin more. Shadish et al. (2002) explain that ruling out such alternatives requires comparing users with similar people who never used the product, ideally with use assigned at random. A claim that a product reduces breakouts is also a health-related efficacy claim, and the Federal Trade Commission (2022) expects health claims of this kind to rest on sound scientific substantiation, typically well-controlled studies, and a follower survey does not qualify.
Supported version: none for advertising. The brand may say that some followers who tried the serum reported clearer skin, but only if it also discloses that this is from a customer survey and is not a clinical result, and the safer course is to run a controlled trial before making any breakout claim.
Claim Three: Women Love the New Formula
Verdict: fails on wording. The figure behind this claim comes from an item asking how much respondents loved the new formula, with options from a little to a lot. The question presumes love and offers no way to say the respondent did not. Schwarz (1999) showed that question wording and response options shape the answers people give, and here they were shaped toward approval. The item cannot support any claim about how much respondents like the formula.
Supported version: none from this item. A future survey should ask respondents to rate the formula on a balanced scale from dislike a lot to like a lot.
Claim Four: Seven in Ten Would Buy It Again
Verdict: survives in modified form. Among surveyed followers who had tried the serum, 71 percent said they would buy it again. The question was neutral and the figure is accurate for that group. The modification is to say whose answer it is.
Table 1
Four Draft Claims and What the Study Supports
| Draft claim | Problem | Verdict | Supported version |
|---|---|---|---|
| Most women prefer the serum to leading brands | Self-selected followers, not women in general | Fails | Most of 1,150 surveyed followers preferred it to brands they had used |
| The serum reduces breakouts | No comparison group; health claim needs controlled evidence | Fails | None for advertising until a controlled trial |
| Women love the new formula | Leading question, no negative option | Fails | None from this item |
| Seven in ten would buy it again | Accurate for the group surveyed | Survives, modified | 71% of surveyed followers who tried it would buy again |
Supported version: 71 percent of our followers who tried the new serum and answered our survey said they would buy it again.
Why Accurate Claims Protect the Brand
The director's concern is understandable: the supported versions sound weaker than the drafts. But the drafts carry risks the supported versions do not. An efficacy claim without controlled evidence invites a regulator's inquiry or a competitor's challenge, and either would cost more than the campaign. A claim about women in general, if challenged, would require the brand to explain that it surveyed its own followers, which would make the brand look careless or misleading. And customers who buy because a serum was said to reduce breakouts, and then see no change, are likely to say so in reviews. The supported versions still say something favorable, that loyal customers like the serum and most would buy it again, and they say it in a way the brand can defend in public.
What the Brand Can Do Next
If the brand wants national claims, it can earn them. A survey of a random sample of women who use facial serums, drawn from a probability-based panel, could support statements about preference among serum users. A controlled trial comparing the serum with a placebo product over eight weeks could support a breakout claim if the results warrant it. Both cost more than a social media link, but both produce claims the brand can defend if challenged by a regulator or a competitor.
Conclusion
Of four draft claims, one survives once it names its group, and three fail on the sample, the design or the wording. The study is useful as evidence of how loyal followers see the serum, and the defense rewrites every claim so that the advertising says no more than the evidence supports.
References
Federal Trade Commission. (2022). Health products compliance guidance. https://www.ftc.gov/
Groves, R. M. (2006). Nonresponse rates and nonresponse bias in household surveys. Public Opinion Quarterly, 70(5), 646-675. https://doi.org/10.1093/poq/nfl033
Schwarz, N. (1999). Self-reports: How the questions shape the answers. American Psychologist, 54(2), 93-105. https://doi.org/10.1037/0003-066X.54.2.93
Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and quasi-experimental designs for generalized causal inference. Houghton Mifflin.
MKT 445 Topic 8 instructions, in plain terms
MKT-445 closes with Topic 8, where students defend the limits of a study against claims that overreach it. Strong defenses take each claim in turn, give a verdict based on the sample, design or wording behind it, support each verdict with research on nonresponse, causal inference and question wording, and consider regulatory expectations for efficacy claims. Students should rewrite every claim in language the evidence supports, explain why accurate claims protect the organization and describe the research that could support stronger claims. The defense should end with the research that could support stronger claims.
How this MKT 445 Topic 8 example is built
Four claims the director drafted are listed in the finished defense, each with a verdict. The first, that most women prefer the serum to leading brands, fails on the sample: 1,150 followers who chose to answer, all figures labeled illustrative, cannot speak for women in general, and followers already favor the brand. The second, that the serum reduces breakouts, fails on design, since a survey showing users report fewer breakouts cannot separate the product from everything else those users do. The third claim rests on an item asking how much respondents loved the new formula, a leading question whose answers overstate approval. The fourth survives in modified form: among surveyed followers who tried the serum, 71 percent said they would buy it again. The defense rewrites every claim in language the evidence supports.
MKT 445 Topic 8 rubric: what Excellent looks like
Faculty reward a defense that redraws claims until the evidence carries them. An Excellent defense rejects the claim about women in general because 1,150 followers chose to answer, citing Groves. Credit goes to rejecting the breakout claim for lacking a comparison group, with Shadish and colleagues and the FTC's guidance. The rubric values tracing the love claim to a leading item, following Schwarz. Strong defenses keep the 71 percent figure while naming its group. Top marks go to explaining how accurate claims protect the brand and what research could earn stronger ones.
Common MKT 445 Topic 8 mistakes, and how to avoid them
Generic limitations, small sample and self-reported data, listed without being tied to a specific claim, are the commonest reason this defense scores low, because the task is deciding which statements survive. Accepting the national claim with a footnote about the sample misses that a footnote does not change what the headline says. Drafts regularly let the breakout claim stand because the percentage is large, when size cannot turn an association into a cause. The leading item is often overlooked, and data from a biased question stays biased however it is analyzed. Rejecting every claim is also marked down, since the survey does support something and the director needs to know what. A defense proposing no route to the stronger claim leaves the brand with a refusal where a plan was possible.
Get an MKT-445 Topic 8 example written to your instructions
Send the MKT-445 Topic 8 instructions and the rubric from your classroom, with the study or case your section assigned. We write a custom example to them, with each claim tested against sample, wording and design, rewritten to fit the evidence and paired with the study that would support more, in 24 to 48 hours. The first one is free.
More MKT 445 papers and BS in Marketing samples
- MKT 445 Topic 1: Decision Problem Statement
- MKT 445 Topic 2: Research Design Rationale
- MKT 445 Topic 3: Secondary Data Audit
- MKT 445 Topic 4: Questionnaire Wording Critique
- MKT 445 Topic 5: Sampling Budget Dq Post
- MKT 445 Topic 6: Survey Data Analysis Plan
- MKT 445 Topic 7: Executive Research Report
- MKT 443 Topic 8: Crm Adoption Plan
- MKT 315 Topic 8: Introductory Marketing Plan
- MKT 433 Topic 8: Sales Plan Defense Memo
- MKT 345 Topic 8: Observable Behavior Explanation Paper
MKT 445 Topic 8 questions, answered
Why can a follower survey not support a national claim?
Because followers are not a sample of the national population. They chose to follow the brand, chose to answer the post and likely hold warmer views than the average buyer. No calculation corrects for that self-selection, because nobody outside the followers had any chance of being included. The results can describe the people who answered, and the example rewrites the claims to say exactly that.
What would it take to support a claim that the serum reduces breakouts?
Usually a controlled test: people randomly assigned to use the serum or a comparison product, with breakouts measured the same way in both groups over the same period. Random assignment spreads other habits evenly between groups, so a difference can be attributed to the product. A survey of existing users cannot do this, because users differ from nonusers in ways the survey never measured.
Is the example giving advertising law advice?
No. It is coursework showing how research evidence limits what a marketer can reasonably claim. Advertising claims are subject to legal standards that vary by product type and jurisdiction, and real decisions about them belong with a qualified attorney. The example includes the brand's legal team as a reader precisely because the research defense and the legal review are separate jobs.
Where can I find a free MKT 445 Topic 8 sample paper?
The limitations defense appears here in full: the study and the request, four claims with verdicts, the claims table, why accurate claims protect the brand, what the brand can do next and the conclusion. Send the claims your case proposes and we will test them free.
Which claim survives in MKT 445 Topic 8?
Only the repurchase figure, rewritten to name its group: 71 percent of surveyed followers who tried the new serum said they would buy it again.